Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: A case report

Journal of Medical Virology

Volumn 76, Issue 3, 2005, Pages 373-377

  Cabrera Rode, Eduardo ^a   Sarmiento, Luis ^b   Molina, Gisela ^a   Pérez, Cecilia ^a   Arranz, Celeste ^a   Galvan, José A ^c   Prieto, Mirta ^d   Barrios, Julio ^b   Palomera, Rosa ^b   Fonseca, Magile ^b   Mas, Pedro ^b   Díaz Díaz, Oscar ^a   Díaz Horta, Oscar ^a  

^a INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^d Hospital Pediatrico Universitario Pedro Borras   (Cuba)

Author keywords

Echovirus; Enterovirus; Epidemic; Islet cell associated antibodies; Type 1 diabetes

Indexed keywords

ANTIBODY; NEUTRALIZING ANTIBODY; PANCREAS ISLET CELL ANTIBODY; TYROSINE PHOSPHATASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CONTROLLED STUDY; DIABETOGENESIS; DIAGNOSTIC KIT; ECHO VIRUS; ENTEROVIRUS; ENTEROVIRUS INFECTION; ENVIRONMENTAL FACTOR; EPIDEMIC; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; SCHOOL CHILD; VIRUS STRAIN;

ADOLESCENT; ARTHRITIS, INFECTIOUS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CUBA; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; NEUTRALIZATION TESTS;

EID: 20044363615     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20368     Document Type: Article

References (27)

1. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. 1995. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40k autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426.
2. Bunce M. 2000. PCR-SSP typing. In: Bedwell JC, Navarrete C, editors. Histocompatibility testing. London: Imperial College Press. pp 149.
3. Cabrera-Rode E, Sarmiento L, Tiberti C, Molina G, Barrios J, Hernández D, Díaz-Horta O, Di Mario U. 2003. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabctologia 46:1348-1353.
4. Centers for Disease Control and Prevention. 2003. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity - United States, 2003. Morbid Mortal Weekly Rep 52:761-764.
5. Craig ME, Howard NJ, Silink M, Rawlinson WD. 2003. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 187:1562-1570.
6. Frisk G, Tuvemo T. 2004. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies. J Med Virol 73:450-459.
7. Haverkos HW, Battula N, Drotman DP, Rennert OM. 2003. Enterovirus and type 1 diabetes mellitus. Biomed Pharm 57:379-385.
8. Hermann R, Knip M, Veijola R, Simell O, Laine AP, Akerbloom HK, Groop PH, Forsblom C, Pettersson-Fernholm K, Ilonen J. 2003. The FinnDiane Study Group. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-Indication of an increased environmental pressure? Diabetologia 46:420-425.
9. Heward JM, Mijovic CH, Kelly Ma, Morrison E, Barnett AH. 2002. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur J Immunogenet 29:47-52.
10. Hyöty H, Taylor KW. 2002. The role of viruses in human diabetes. Diabetologia 45:1353-1361.
11. Knip M, Akerblom HK. 1999. Environmental factors in the pathogenesis of type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 107: S93-S100.
12. Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS. 2003. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 88:103-108.
13. Kulmala P, Savola K, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Ilonen J, Tuomilehto J, Akerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. 2000. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes 49:48-58.
14. Lönnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P, Hyypiä T, Akerblom HK, Hyöty H, the Childhood Diabetes in Finland (DiMe) Study Group. 2000. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: A prospective study. J Med Virol 61:214-220.
15. Oberste S, Maher K, Kennett M, Campbell J, Carpenter M, Schnurr D. 1999. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): Genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol 37:3928-3933.
16. Otonkoski T, Rovainen M, Vaarala O, Dinesen B, Leipälä JA, Hovi T, Knip M. 2000. Neonatal type 1 diabetes associated with maternal echovirus 6 infection: A case report. Diabetologia 43:1235-1238.
17. Redondo MJ, Fain PR, Eisenbarth GS. 2001. Genetic of type 1A diabetes. Recent Prog Horm Res 56:69-89.
18. Rovainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. 2002. Functional impairment and killing of human beta cells by enterovirus: The capacity is shared by a wide range of serotypes, but the extend is characteristic of individual virus strains. Diabetologia 45:693-702.
19. Sarmiento L. 2004. Enteroviral meningitis and emergence of rare enterovirus types: Cuban experience. In: Strong P, editor. Focus on meningitis research. New York: Nova Science Publishers, Inc. pp 1-14.
20. Sarmiento L, Mas P, Goyenechea A, Palomera R, Morier L, Capo V, Quintana I, Santin M. 2001. First epidemic of echovirus 16 meningitis in Cuba. Emerg Infect Dis 7:887-889.
21. Schmidli RS, Colman PG, Bonifacio E. 1995. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44:636-640.
22. Trinder P. 1969. Determination of glucose oxidase with one alternative oxygen acceptor. Ann Clin Biochem 6:24-27.
23. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Radizabeth A, Riley WJ, MacLaren NK, Eisenbarth GS, Soeldner JS. 1987. Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type 1 diabetes mellitus. Diabetes 36:1286-1291.
24. Viskari H, Ludvigsson Uibo R, Salur L, Marciulionyte D, Hermann R, Soltesz G, Füchtenbusch M, Ziegler AG, Kondrashova A, Romanov A, Knip M, Hyoty H. 2004. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations. Results from the EPIVIR project. J Med Virol 72:610-617.
25. Vreugdenhil GR, Schloot NC, Hoorens A, Rongen C, Pipeleers DG, Melchers WJG, Roep BO, Galama JMD. 2000. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: Putative pathogenic pathways. Clin Infect Dis 31:1025-1031.
26. WHO/EPI/01. 1997. Manual for the virological investigation of polio, Geneva, Switzerland WHO/EPI/GEN/97.01 1997:44-51.
27. Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P. 2003. Glutamic acid decarboxylase and ICA512/IA2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients. Metabolism 52:25-29.